Cleared Traditional

CIMILRE Free-T2 Plus (K221708) - FDA 510(k) Clearance

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K221708 · Cimilre Co., Ltd. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2022
Decision
193d
Days
Class 2
Risk

K221708 is an FDA 510(k) clearance for the CIMILRE Free-T2 Plus. Classified as Pump, Breast, Powered (product code HGX), Class II - Special Controls.

Submitted by Cimilre Co., Ltd. (Cheonan-Si, KR). The FDA issued a Cleared decision on December 23, 2022 after a review of 193 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.5160 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Cimilre Co., Ltd. devices

Submission Details

510(k) Number K221708 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 13, 2022
Decision Date December 23, 2022
Days to Decision 193 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
33d slower than avg
Panel avg: 160d · This submission: 193d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code HGX Pump, Breast, Powered
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.5160
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Consultant

Third Party Review Group, LLC
DAVE YUNGVIRT

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - HGX Pump, Breast, Powered

All 127
Devices cleared under the same product code (HGX) and FDA review panel - the closest regulatory comparables to K221708.
imani i2Plus Breast Pump
K222573 · Imani Co. · Mar 2023
Wearable Breast Pump (Model:YD-1193,YD-1195,YD-1196,YD-1198,YD-1199
K222782 · Zhejiang Carebao Co., Ltd. · Jan 2023
Wearable Breast Pump (Model S1DW)
K222045 · Shenzhen TPH Technology Co., Ltd. · Jan 2023
Smartpump 3.0 Double Electric Breast Pump
K222726 · Lansinoh Laboratories · Dec 2022
Spectra Wearable
K220926 · Uzinmedicare Co., Ltd. · Dec 2022
Wearable breast pump
K221598 · Mayborn (Uk) Limited · Dec 2022

Related FDA 510(k) Regulatory Insights

Additional regulatory intelligence related to this FDA 510(k) submission, including predicate strategy, review pathways and device classification guidance.